MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cognitive complaint in Parkinson’s disease patients with normal cognition: Canary in the coal mine?

R. Purri, L. Brennan, J. Rick, S. Xie, B. Deck, L. Chahine, N. Dahodwala, A. Chen-Plotkin, J. Duda, J. Morley, R. Akhtar, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

Meeting: 2019 International Congress

Abstract Number: 1723

Keywords: Cognitive dysfunction

Session Information

Date: Wednesday, September 25, 2019

Session Title: Cognition and Cognitive Disorders

Session Time: 1:15pm-2:45pm

Location: Agora 3 East, Level 3

Objective: To determine the frequency and impact of cognitive complaints in Parkinson’s disease (PD) patients with normal cognition (NC).

Background: PD patients are at a high risk for developing mild cognitive impairment (MCI) or dementia (PDD), yet little is known about the progression from normal cognition (NC) to MCI or PDD. This is of particular importance in the context of the shift in the neurodegenerative disease research landscape to focus on preclinical and prodromal patients in an effort to develop more effective and timely intervention strategies.

Method: PD patients with expert consensus-determined NC at baseline were asked a single question regarding subjective presence of cognitive complaints. Baseline (n=154) and longitudinal (n=123) between-group differences in PD patients with (+CC) and without (-CC) cognitive complaints were examined, including both global and detailed cognitive test performance, and self- and informant-rated functional abilities.

Results: Eighty-two (53%) participants reported a cognitive complaint. At baseline there were no between-group differences in cognition. Longitudinally the +CC group declined more than the -CC group on global cognition (Mattis Dementia Rating Scale-2 total score (F=(1, 435)=5.28; p=0.02) and two detailed cognitive tests (Symbol Digit Modalities Test (F=(1, 334.52)=5.98; p=0.02); Trails B (F=(1, 325.46)=6.23; p=0.01). The +CC group also demonstrated significantly lower self- and knowledgeable informant-reported cognition-related functional abilities at baseline, and declined more on an assessment of global functional abilities longitudinally.

Conclusion: PD patients with normal cognition by expert consensus process, but with subjective cognitive complaint, perform worse on cognition-specific functional abilities and decline more over time on measures of global cognition, executive abilities, and global functional abilities. These findings suggest that subjective cognitive complaints and assessment of cognition-related functional abilities may be sensitive indicators of initial cognitive decline in PD with long-term prognostic significance.

To cite this abstract in AMA style:

R. Purri, L. Brennan, J. Rick, S. Xie, B. Deck, L. Chahine, N. Dahodwala, A. Chen-Plotkin, J. Duda, J. Morley, R. Akhtar, J. Trojanowski, D. Weintraub. Cognitive complaint in Parkinson’s disease patients with normal cognition: Canary in the coal mine? [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/cognitive-complaint-in-parkinsons-disease-patients-with-normal-cognition-canary-in-the-coal-mine/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cognitive-complaint-in-parkinsons-disease-patients-with-normal-cognition-canary-in-the-coal-mine/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley